Multiplex Assay Market by Type (Nucleic Acid-Based Multiplex Assays, Protein-Based Multiplex Assays, and Others), Product (Multiplex Assay Reagents & Consumables, Multiplex Assay Accessories & Instruments, and Multiplex Assay Software & Services), Technology (Multiplex PCR, Multiplex Protein Microarray, and Others), Application (Companion Diagnostics, Research & Development (Drug Development and Biomarker Discovery & Validation), and Clinical Diagnostics) and End User (Hospitals, Clinical Laboratories, Research Institutes, and Pharmaceuticals & Biotechnological Companies): Global Opportunity Analysis and Industry Forecast, 20192026
- Published Date: 2020-10-18
- Report ID: 3601
- Pages: 289
-
Format:
The global multiplex assays market accounted for $73.2 million in 2018, and is expected to reach $123.1 million by 2026, growing at a CAGR of 6.6% from 2019 to 2026.
Multiplex immunoassays conjugates assays for several target analytes in a single reaction volume, minimizing workflow and sample volume difficulties. In addition, this assay provides a gain in assay dynamic range, and is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as singleplex ELISA. Multiplex assays finds its application in pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.
Multiplex assays hold enormous potential in the R&D of drugs for the treatment of diseases, such as cancer and cardiovascular diseases that drives the market growth for theses assays. For instance, bead-based Luminex xMAP multiplex assay provides a platform for cancer biomarker assays, which are compatible with plasma, serum, cultured cells, and other biological samples. In addition, surge in adoption of multiplex assays to reduce operation costs and rise in adoption of personalized medicines are anticipated to boost the market growth. However, high capital investment and dearth of skilled labors are the major factors that hinder the market growth. On the contrary, the emerging economies of Asia-Pacific and LAMEA regions offer lucrative growth opportunities for the expansion of multiplex assays market, due to improvement in healthcare infrastructure in these regions and increase in demand for better healthcare services from majority of the patient population.
The global multiplex assays market in this report is studied based on type, product, technology, application, end user, and region. On the basis of type, the market is divided into nucleic acid-based, protein-based multiplex assays, and others. By product, it is classified into multiplex assay reagents & consumables, multiplex assay instruments & accessories, and multiplex assay software & services. Depending on technology, it is fragmented into nucleic acid-based, protein-based multiplex assays, and others. As per application, it is segregated into companion diagnostics, research & development, clinical diagnostics, and others. According to end user, it is classified into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnological companies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global multiplex assay market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps to understand the global trends in the multiplex assay market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Type
Nucleic Acid-based Multiplex Assays
Protein-based Multiplex Assays
Others
By Product
Multiplex Assay Reagents & Consumables
Multiplex Assay Instruments & Accessories
Multiplex Assay Software & Services
By Technology
Multiplex PCR
Multiplex Protein Microarray
Others
By Application
Companion Diagnostics
Research & Development
Clinical Diagnostics
End User
Hospitals
Clinical Laboratories
Research Institutes
Pharmaceuticals & Biotechnological Companies
By Region
o North America
U.S.
Canada
Mexico
o Europe
UK
France
Germany
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
South Korea
Australia
Rest of Asia-Pacific
o LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA
KEY MARKET PLAYERS
Luminex Corporation
Thermo Fisher Scientific Inc.
Illumina Inc.
Bio-Rad Laboratories Inc.
QIAGEN N.V.
Becton, Dickinson and Company
Abcam PLC
Seegene Inc.
Randox Laboratories Ltd.
The other players in the value chain include (profiles not included in the report)
Merck KGaA
Agilent Technologies
Quanterix
Olink
Sysmex Corporation
Siemens Healthcare GmbH
F. Hoffmann-La Roche Ltd
Johnson & Johnson
HAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porters five forces analysis
3.3.1. Moderate bargaining power of buyers
3.3.2. Low bargaining power of suppliers
3.3.3. Moderate threat of substitutes
3.3.4. Low threat of new entrants
3.3.5. Moderate competitive rivalry
3.4. Market share analysis, 2018
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in R&D activities & governmental funding
3.5.1.2. Surge in adoption of multiplex assays to reduce operation costs
3.5.1.3. Rise in adoption of personalized medicines
3.5.2. Restraint
3.5.2.1. Lack of skilled labor/healthcare professionals
3.5.3. Opportunity
3.5.3.1. Various growth opportunities in emerging economies
CHAPTER 4: MULTIPLEX ASSAYS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Nucleic acid-based multiplex assays
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market share analysis, by country
4.3. Protein-based multiplex assays
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market share analysis, by country
4.4. Others
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market share analysis, by country
CHAPTER 5: MULTIPLEX ASSAYS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Multiplex assays reagents & consumables
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast
5.2.3. Market share analysis, by country
5.3. Multiplex assays instruments & accessories
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
5.3.3. Market share analysis, by country
5.4. Multiplex assay software & services
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast
5.4.3. Market share analysis, by country
CHAPTER 6: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. Multiplex PCR
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast
6.2.3. Market share analysis, by country
6.3. Multiplex protein microarray
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast
6.3.3. Market share analysis, by country
6.3.4. Immunohistochemistry
6.3.4.1. Market size and forecast
6.4. Other technologies
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast
6.4.3. Market share analysis, by country
CHAPTER 7: MULTIPLEX ASSAYS MARKET, BY APPLICATION
7.1. Overview
7.1.1. Market size and forecast
7.2. Companion diagnostics
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast
7.2.3. Market share analysis, by country
7.3. Research & development
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast
7.3.3. Market share analysis, by country
7.4. Clinical diagnostics
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast
7.4.3. Market share analysis, by country
CHAPTER 8: MULTIPLEX ASSAYS MARKET, BY END USER
8.1. Overview
8.1.1. Market size and forecast
8.2. Hospitals
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast
8.2.3. Market share analysis, by country
8.3. Clinical laboratories
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast
8.3.3. Market share analysis, by country
8.4. Research institutes
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast
8.4.3. Market share analysis, by country
8.5. Pharmaceuticals & biotechnology companies
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast
8.5.3. Market share analysis, by country
CHAPTER 9: MULTIPLEX ASSAYS MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast
9.2. North America
9.2.1. Key market trends and opportunities
9.2.2. Market size and forecast, by country
9.2.3. Market size and forecast, by type
9.2.4. Market size and forecast, by product
9.2.5. Market size and forecast, by technology
9.2.6. Market size and forecast, by application
9.2.7. Market size and forecast, by end user
9.2.8. U.S.
9.2.8.1. U.S. market size and forecast, by type
9.2.8.2. U.S. market size and forecast, by product
9.2.8.3. U.S. market size and forecast, by technology
9.2.8.4. U.S. market size and forecast, by application
9.2.8.5. U.S. market size and forecast, by end user
9.2.9. Canada
9.2.9.1. Canada market size and forecast, by type
9.2.9.2. Canada market size and forecast, by product
9.2.9.3. Canada market size and forecast, by technology
9.2.9.4. Canada market size and forecast, by application
9.2.9.5. Canada market size and forecast, by end user
9.2.10. Mexico
9.2.10.1. Mexico market size and forecast, by type
9.2.10.2. Mexico market size and forecast, by product
9.2.10.3. Mexico market size and forecast, by technology
9.2.10.4. Mexico market size and forecast, by application
9.2.10.5. Mexico market size and forecast, by end user
9.3. Europe
9.3.1. Key growth factors and opportunities
9.3.2. Market size and forecast, by country
9.3.3. Market size and forecast, by type
9.3.4. Market size and forecast, by product
9.3.5. Market size and forecast, by technology
9.3.6. Market size and forecast, by application
9.3.7. Market size and forecast, by end user
9.3.8. Germany
9.3.8.1. Germany market size and forecast, by type
9.3.8.2. Germany market size and forecast, by product
9.3.8.3. Germany market size and forecast, by technology
9.3.8.4. Germany market size and forecast, by application
9.3.8.5. Germany market size and forecast, by end user
9.3.9. France
9.3.9.1. France market size and forecast, by type
9.3.9.2. France market size and forecast, by product
9.3.9.3. France market size and forecast, by technology
9.3.9.4. France market size and forecast, by application
9.3.9.5. France market size and forecast, by end user
9.3.10. UK
9.3.10.1. UK market size and forecast, by type
9.3.10.2. UK market size and forecast, by product
9.3.10.3. UK market size and forecast, by technology
9.3.10.4. UK market size and forecast, by application
9.3.10.5. UK market size and forecast, by end user
9.3.11. Italy
9.3.11.1. Italy market size and forecast, by type
9.3.11.2. Italy market size and forecast, by product
9.3.11.3. Italy market size and forecast, by technology
9.3.11.4. Italy market size and forecast, by application
9.3.11.5. Italy market size and forecast, by end user
9.3.12. Spain
9.3.12.1. Spain market size and forecast, by type
9.3.12.2. Spain market size and forecast, by product
9.3.12.3. Spain market size and forecast, by technology
9.3.12.4. Spain market size and forecast, by application
9.3.12.5. Spain market size and forecast, by end user
9.3.13. Rest of Europe
9.3.13.1. Rest of Europe market size and forecast, by type
9.3.13.2. Rest of Europe market size and forecast, by product
9.3.13.3. Rest of Europe market size and forecast, by technology
9.3.13.4. Rest of Europe market size and forecast, by application
9.3.13.5. Rest of Europe market size and forecast, by end user
9.4. Asia-Pacific
9.4.1. Key growth factors and opportunities.
9.4.2. Market size and forecast, by country
9.4.3. Market size and forecast, by type
9.4.4. Market size and forecast, by product
9.4.5. Market size and forecast, by technology
9.4.6. Market size and forecast, by application
9.4.7. Market size and forecast, by end user
9.4.8. Japan
9.4.8.1. Japan market size and forecast, by type
9.4.8.2. Japan market size and forecast, by product
9.4.8.3. Japan market size and forecast, by technology
9.4.8.4. Japan market size and forecast, by application
9.4.8.5. Japan market size and forecast, by end user
9.4.9. China
9.4.9.1. China market size and forecast, by type
9.4.9.2. China market size and forecast, by product
9.4.9.3. China market size and forecast, by technology
9.4.9.4. China market size and forecast, by application
9.4.9.5. China market size and forecast, by end user
9.4.10. India
9.4.10.1. India market size and forecast, by type
9.4.10.2. India market size and forecast, by product
9.4.10.3. India market size and forecast, by technology
9.4.10.4. India market size and forecast, by application
9.4.10.5. India market size and forecast, by end user
9.4.11. Rest of Asia-Pacific
9.4.11.1. Rest of Asia-Pacific market size and forecast, by type
9.4.11.2. Rest of Asia-Pacific market size and forecast, by product
9.4.11.3. Rest of Asia-Pacific market size and forecast, by technology
9.4.11.4. Rest of Asia-Pacific market size and forecast, by application
9.4.11.5. Rest of Asia-Pacific market size and forecast, by end user
9.5. LAMEA
9.5.1. Key growth factors and opportunities
9.5.2. Market size and forecast, by country
9.5.3. Market size and forecast, by type
9.5.4. Market size and forecast, by product
9.5.5. Market size and forecast, by technology
9.5.6. Market size and forecast, by application
9.5.7. Market size and forecast, by end user
9.5.8. Brazil
9.5.8.1. Brazil market size and forecast, by type
9.5.8.2. Brazil market size and forecast, by product
9.5.8.3. Brazil market size and forecast, by technology
9.5.8.4. Brazil market size and forecast, by application
9.5.8.5. Brazil market size and forecast, by end user
9.5.9. Saudi Arabia
9.5.9.1. Saudi Arabia market size and forecast, by type
9.5.9.2. Saudi Arabia market size and forecast, by product
9.5.9.3. Saudi Arabia market size and forecast, by technology
9.5.9.4. Saudi Arabia market size and forecast, by application
9.5.9.5. Saudi Arabia market size and forecast, by end user
9.5.10. South Africa
9.5.10.1. South Africa market size and forecast, by type
9.5.10.2. South Africa market size and forecast, by product
9.5.10.3. South Africa market size and forecast, by technology
9.5.10.4. South Africa market size and forecast, by application
9.5.10.5. South Africa market size and forecast, by end user
9.5.11. Rest of LAMEA
9.5.11.1. Rest of LAMEA market size and forecast, by type
9.5.11.2. Rest of LAMEA market size and forecast, by product
9.5.11.3. Rest of LAMEA market size and forecast, by technology
9.5.11.4. Rest of LAMEA market size and forecast, by application
9.5.11.5. Rest of LAMEA market size and forecast, by end user
CHAPTER 10: COMPANY PROFILES
10.1. ABCAM PLC.
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio
10.1.5. Business performance
10.2. BECTON, DICKINSON AND COMPANY
10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Product portfolio
10.2.5. Business performance
10.3. MESO SCALE DIAGNOSTICS, LLC.
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Key strategic moves and developments
10.4. RANDOX LABORATORIES LTD.
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.5. SEEGENE INC.
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product Portfolio
10.5.5. Business performance
10.5.6. Key strategic moves and developments
10.6. BIO-RAD LABORATORIES, INC.
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product Portfolio
10.6.5. Business performance
10.7. ILLUMINA, INC.
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance
10.8. QIAGEN N.V.
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Business performance
10.8.5. Key strategic moves and developments
10.9. THERMO FISHER SCIENTIFIC, INC.
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Business performance
10.10. LUMINEX CORPORATION
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5. Business performance
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
